Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPVs

Details for Australian Patent Application No. 2006213114 (hide)

International Classifications

Event Publications

16 August 2007 PCT application entered the National Phase

PCT publication WO2006/085822 Priority application(s): WO2006/085822

13 September 2007 Change of Name(s) of Applicant(s), Section 104

Canag Diagnostics AB The name of the applicant has been changed to Fujirebio Diagnostics AB

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.